Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G Beach

Showing results (451-460 of 653) with videos related to

Pageof 66
Sort By:
Genes|June 2, 2021
A Genetic Study of Cerebral Atherosclerosis Reveals Novel Associations with <i>NTNG1</i> and CNOT3Selina M Vattathil, Yue Liu, Nadia V Harerimana, et al.
Biorxiv : the Preprint Server for Biology|April 3, 2026
Integrating Long-Read Structural Variant Analysis with single-nucleus RNA-seq to Elucidate Gene Expression Effects in DiseaseKwanho Kim, Zechuan Lin, Sean K Simmons, et al.
Medrxiv : the Preprint Server for Health Sciences|May 7, 2026
Olfactory decline in aging: longitudinal trajectories and associations with cognitive decline and postmortem neuropathologyCecilia Tremblay, Parichita Choudhury, Erika Driver-Dunckley, et al.
Proceedings of the National Academy of Sciences of the United States of America|March 12, 2008
Alzheimer's disease is associated with reduced expression of energy metabolism genes in posterior cingulate neuronsWinnie S Liang, Eric M Reiman, Jon Valla, et al.
Movement Disorders Clinical Practice|October 27, 2018
Are Clinical Certainty Ratings Helpful in the Diagnosis of Parkinson's Disease?Harsh V Gupta, Shyamal H Mehta, Nan Zhang, et al.
Biorxiv : the Preprint Server for Biology|February 6, 2026
Dyrk1a inhibition with the Novel Compound DYR533: A Cross-Disease Therapeutic Strategy Targeting Amyloidosis, Tau Pathogenesis, and NeuroinflammationS K Bartholomew, J Turk, W Winslow, et al.
Biorxiv : the Preprint Server for Biology|November 24, 2025
Transcriptomic profiling of the middle temporal gyrus reveals differential glial/neuronal dysregulation across Alzheimer's disease and agingI S Piras, A Bonfitto, S Song, et al.
Journal of Neuropathology and Experimental Neurology|February 22, 2022
Hemispheric Asymmetry and Atypical Lobar Progression of Alzheimer-Type TauopathyCécilia Tremblay, Geidy E Serrano, Anthony J Intorcia, et al.
Alzheimer Disease and Associated Disorders|October 9, 2009
Parkinson disease with dementia: comparing patients with and without Alzheimer pathologyMarwan N Sabbagh, Charles H Adler, Tyson J Lahti, et al.
Acta Neuropathologica|December 3, 2024
Identification of isoAsp7-Aβ as a major Aβ variant in Alzheimer's disease, dementia with Lewy bodies and vascular dementiaSarah Schrempel, Anna Katharina Kottwitz, Anke Piechotta, et al.
Pageof 66

Showing results (451-460 of 653) with videos related to

Sort By:
Pageof 66
Genes|June 2, 2021
A Genetic Study of Cerebral Atherosclerosis Reveals Novel Associations with <i>NTNG1</i> and CNOT3Selina M Vattathil, Yue Liu, Nadia V Harerimana, et al.
Biorxiv : the Preprint Server for Biology|April 3, 2026
Integrating Long-Read Structural Variant Analysis with single-nucleus RNA-seq to Elucidate Gene Expression Effects in DiseaseKwanho Kim, Zechuan Lin, Sean K Simmons, et al.
Medrxiv : the Preprint Server for Health Sciences|May 7, 2026
Olfactory decline in aging: longitudinal trajectories and associations with cognitive decline and postmortem neuropathologyCecilia Tremblay, Parichita Choudhury, Erika Driver-Dunckley, et al.
Proceedings of the National Academy of Sciences of the United States of America|March 12, 2008
Alzheimer's disease is associated with reduced expression of energy metabolism genes in posterior cingulate neuronsWinnie S Liang, Eric M Reiman, Jon Valla, et al.
Movement Disorders Clinical Practice|October 27, 2018
Are Clinical Certainty Ratings Helpful in the Diagnosis of Parkinson's Disease?Harsh V Gupta, Shyamal H Mehta, Nan Zhang, et al.
Biorxiv : the Preprint Server for Biology|February 6, 2026
Dyrk1a inhibition with the Novel Compound DYR533: A Cross-Disease Therapeutic Strategy Targeting Amyloidosis, Tau Pathogenesis, and NeuroinflammationS K Bartholomew, J Turk, W Winslow, et al.
Biorxiv : the Preprint Server for Biology|November 24, 2025
Transcriptomic profiling of the middle temporal gyrus reveals differential glial/neuronal dysregulation across Alzheimer's disease and agingI S Piras, A Bonfitto, S Song, et al.
Journal of Neuropathology and Experimental Neurology|February 22, 2022
Hemispheric Asymmetry and Atypical Lobar Progression of Alzheimer-Type TauopathyCécilia Tremblay, Geidy E Serrano, Anthony J Intorcia, et al.
Alzheimer Disease and Associated Disorders|October 9, 2009
Parkinson disease with dementia: comparing patients with and without Alzheimer pathologyMarwan N Sabbagh, Charles H Adler, Tyson J Lahti, et al.
Acta Neuropathologica|December 3, 2024
Identification of isoAsp7-Aβ as a major Aβ variant in Alzheimer's disease, dementia with Lewy bodies and vascular dementiaSarah Schrempel, Anna Katharina Kottwitz, Anke Piechotta, et al.
Pageof 66